Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Fung Lin

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Anticancer Research|July 31, 2012
Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trialChih-Yuan Chung, Sheng-Fung Lin, Po-Min Chen, et al.
Japanese Journal of Clinical Oncology|August 22, 2015
The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in TaiwanKun-Ming Rau, Jen-Shi Chen, Hung-Bo Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 26, 2016
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in TaiwanShang-Yi Huang, Yuan-Bin Yu, Su-Peng Yeh, et al.
Hepatology (Baltimore, Md.)|September 5, 2013
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective studyChiun Hsu, Hsiao-Hui Tsou, Shyh-Jer Lin, et al.
European Journal of Haematology|June 25, 2014
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphomaHui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.
Therapeutic Advances in Hematology|March 14, 2018
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL studyChing-Yuan Kuo, Po-Nan Wang, Wen-Li Hwang, et al.
Scientific Reports|September 14, 2017
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia PatientsHui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, et al.
Hepatology (Baltimore, Md.)|February 28, 2008
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trialChiun Hsu, Chao A Hsiung, Ih-Jen Su, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Anticancer Research|July 31, 2012
Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trialChih-Yuan Chung, Sheng-Fung Lin, Po-Min Chen, et al.
Japanese Journal of Clinical Oncology|August 22, 2015
The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in TaiwanKun-Ming Rau, Jen-Shi Chen, Hung-Bo Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 26, 2016
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in TaiwanShang-Yi Huang, Yuan-Bin Yu, Su-Peng Yeh, et al.
Hepatology (Baltimore, Md.)|September 5, 2013
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective studyChiun Hsu, Hsiao-Hui Tsou, Shyh-Jer Lin, et al.
European Journal of Haematology|June 25, 2014
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphomaHui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.
Therapeutic Advances in Hematology|March 14, 2018
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL studyChing-Yuan Kuo, Po-Nan Wang, Wen-Li Hwang, et al.
Scientific Reports|September 14, 2017
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia PatientsHui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, et al.
Hepatology (Baltimore, Md.)|February 28, 2008
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trialChiun Hsu, Chao A Hsiung, Ih-Jen Su, et al.
Pageof 13